Award recordCONTRACT

BECKMAN COULTER, INC

PIID VA25612J1538· VHA· 502-ALEXANDRIA· Q301 · MEDICAL- LABORATORY TESTING· FY2012· $131,583 net obligations· UEI PU6HHX2R11C7· CA

Description

IGF::OT::IGF CHEMISTRY-IMMUNO COST PER REPORTABLE RESULTS-DEOBLIGATION OF EXCESS FUNDS

Base award description: CHEMISTRY-IMMUNO COST PER REPORTABLE RESULTS

First action · last action
2012-05-03 · 2013-02-12
Transactions
2
First transaction's obligation
$139,000
Base + all options value (sum of deltas)
$131,583
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA256BP0103
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$139,000$0Base award · 2012-05-03 · this action $139,000 · running total $139,000Modification P00001 · 2013-02-12 · this action -$7,417 · running total $131,583
  • Base2012-05-03+$139,000= $139,000
  • Mod P000012013-02-12-$7,417= $131,583
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2012-05-03+$139,000$139,000CHEMISTRY-IMMUNO COST PER REPORTABLE RESULTS
Mod P00001· CLOSE OUT2013-02-12−$7,417$131,583IGF::OT::IGF CHEMISTRY-IMMUNO COST PER REPORTABLE RESULTS-DEOBLIGATION OF EXCESS FUNDS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI PU6HHX2R11C7)

AwardOffice · PSC / listingNet obligationsFY
36C26226N0869262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$111,853FY2026
36C25726N0476257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$1,450,556FY2026
36C25926N0424NETWORK CONTRACT OFFICE 19 (36C259) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS$2,989,154FY2026
36C25726N0456257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$365,580FY2026
36C24426N0923244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING$84,816FY2026
36C24426N0922244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING$46,600FY2026

Other recipients under Q301 from 502-ALEXANDRIA (most recent first)

AwardRecipientOfficeNet obligationsFY
VA25613P0013CYTYC CORPORATION502-ALEXANDRIA$5,280FY2013
VA25612J1923POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC502-ALEXANDRIA$16,154FY2012
VA25612J1542TOSOH BIOSCIENCE, INC.502-ALEXANDRIA$10,000FY2012
VA25612J1541IRIS INTERNATIONAL, INC.502-ALEXANDRIA$22,813FY2012
VA25612J1375POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC502-ALEXANDRIA$15,901FY2012

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25612J1538_3600_VA256BP0103_3600 · retrieved 2026-09-26.